Qiuyu Zhang-Qiuyu

Fuzhou, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Fully human anti-B7-H4 antibody induces lysosome-dependent ferroptosis to reverse primary resistance to PD-1 blockade.

Fully human anti-B7-H4 antibody induces lysosome-dependent ferroptosis to reverse primary resistance to PD-1 blockade.

Journal: Journal for immunotherapy of cancer

Published: December 19, 2025

The absence of B7-H4 inhibits PD-L1 expression by driving a methylation of PD-L1 promoter in breast cancer cells.

The absence of B7-H4 inhibits PD-L1 expression by driving a methylation of PD-L1 promoter in breast cancer cells.

Journal: Breast cancer research : BCR

Published: October 30, 2025

Insufficient ferroptosis in radiation-induced tumor cells promote Treg cell generation to induce radiotherapy resistance.

Insufficient ferroptosis in radiation-induced tumor cells promote Treg cell generation to induce radiotherapy resistance.

Journal: Communications biology

Published: June 14, 2025

RNASEH2C enhances TRAF3IP1 to degrade RAI14 in lysosomes thus hindering macrophage antigen presentation and advancing liver cancer.

RNASEH2C enhances TRAF3IP1 to degrade RAI14 in lysosomes thus hindering macrophage antigen presentation and advancing liver cancer.

Journal: Cell death & disease

Published: April 10, 2025

Ly6E on tumor cells impairs anti-tumor T-cell responses: a novel mechanism of tumor-induced immune exclusion.

Ly6E on tumor cells impairs anti-tumor T-cell responses: a novel mechanism of tumor-induced immune exclusion.

Journal: Cancer immunology, immunotherapy : CII

Published: April 09, 2024

The loss of B7-H4 expression in breast cancer cells escaping from T cell cytotoxicity contributes to epithelial-to-mesenchymal transition.

The loss of B7-H4 expression in breast cancer cells escaping from T cell cytotoxicity contributes to epithelial-to-mesenchymal transition.

Journal: Breast cancer research : BCR

Published: February 21, 2023

MiR-223-3p attenuates radiation-induced inflammatory response and inhibits the activation of NLRP3 inflammasome in macrophages.

MiR-223-3p attenuates radiation-induced inflammatory response and inhibits the activation of NLRP3 inflammasome in macrophages.

Journal: International immunopharmacology

Published: December 08, 2022

Delicaflavone reactivates anti-tumor immune responses by abrogating monocytic myeloid cell-mediated immunosuppression.

Delicaflavone reactivates anti-tumor immune responses by abrogating monocytic myeloid cell-mediated immunosuppression.

Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology

Published: June 24, 2022

Identification of unanimous immune subtypes for different hormone receptor phenotypes of human breast cancer with potential prognostic significance.

Identification of unanimous immune subtypes for different hormone receptor phenotypes of human breast cancer with potential prognostic significance.

Journal: International immunopharmacology

Published: November 14, 2020

MiR-7-5p-mediated downregulation of PARP1 impacts DNA homologous recombination repair and resistance to doxorubicin in small cell lung cancer.

MiR-7-5p-mediated downregulation of PARP1 impacts DNA homologous recombination repair and resistance to doxorubicin in small cell lung cancer.

Journal: BMC cancer

Published: March 08, 2019

B7H4 expression in tumor cells impairs CD8 T cell responses and tumor immunity.

B7H4 expression in tumor cells impairs CD8 T cell responses and tumor immunity.

Journal: Cancer immunology, immunotherapy : CII

Published: January 23, 2019

Showing 1-11 of 11

Last Updated: 09/26/2026